227 related articles for article (PubMed ID: 33237535)
1. Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients.
Bruderek K; Schirrmann R; Brandau S
Methods Mol Biol; 2021; 2236():1-7. PubMed ID: 33237535
[TBL] [Abstract][Full Text] [Related]
2. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
[No Abstract] [Full Text] [Related]
3. Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells.
Nagatani Y; Funakoshi Y; Suto H; Imamura Y; Toyoda M; Kiyota N; Yamashita K; Minami H
J Cancer Res Ther; 2021; 17(4):1093-1100. PubMed ID: 34528569
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Generation of Human Neutrophilic Myeloid-Derived Suppressor Cells.
Singh A; Rieber N
Methods Mol Biol; 2021; 2236():77-83. PubMed ID: 33237542
[TBL] [Abstract][Full Text] [Related]
5. Isolation and Phenotyping of Splenic Myeloid-Derived Suppressor Cells in Murine Cancer Models.
Sanseviero E; Kim R; Gabrilovich DI
Methods Mol Biol; 2021; 2236():19-28. PubMed ID: 33237537
[TBL] [Abstract][Full Text] [Related]
6. Isolation of Human Circulating Myeloid-Derived Suppressor Cells and Analysis of Their Immunosuppressive Activity.
Bruderek K; Schirrmann R; Brandau S
Methods Mol Biol; 2021; 2236():43-56. PubMed ID: 33237539
[TBL] [Abstract][Full Text] [Related]
7. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
[TBL] [Abstract][Full Text] [Related]
8. Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation.
Cassetta L; Bruderek K; Skrzeczynska-Moncznik J; Osiecka O; Hu X; Rundgren IM; Lin A; Santegoets K; Horzum U; Godinho-Santos A; Zelinskyy G; Garcia-Tellez T; Bjelica S; Taciak B; Kittang AO; Höing B; Lang S; Dixon M; Müller V; Utikal JS; Karakoç D; Yilmaz KB; Górka E; Bodnar L; Anastasiou OE; Bourgeois C; Badura R; Kapinska-Mrowiecka M; Gotic M; Ter Laan M; Kers-Rebel E; Król M; Santibañez JF; Müller-Trutwin M; Dittmer U; de Sousa AE; Esendağlı G; Adema G; Loré K; Ersvær E; Umansky V; Pollard JW; Cichy J; Brandau S
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32907925
[TBL] [Abstract][Full Text] [Related]
9. Plasticity of myeloid-derived suppressor cells in cancer.
Tcyganov E; Mastio J; Chen E; Gabrilovich DI
Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometry-based immunophenotyping of myeloid-derived suppressor cells in human breast cancer patient blood samples.
Lee EJ; Jung S; Park KH; Park SI
J Immunol Methods; 2022 Nov; 510():113348. PubMed ID: 36058258
[TBL] [Abstract][Full Text] [Related]
11. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.
Karin N
Front Immunol; 2020; 11():557586. PubMed ID: 33193327
[TBL] [Abstract][Full Text] [Related]
12. Early Posttransplant Mobilization of Monocytic Myeloid-derived Suppressor Cell Correlates With Increase in Soluble Immunosuppressive Factors and Predicts Cancer in Kidney Recipients.
Utrero-Rico A; Laguna-Goya R; Cano-Romero F; Chivite-Lacaba M; Gonzalez-Cuadrado C; Rodríguez-Sánchez E; Ruiz-Hurtado G; Serrano A; Fernández-Ruiz M; Justo I; González E; Andrés A; Paz-Artal E
Transplantation; 2020 Dec; 104(12):2599-2608. PubMed ID: 32068661
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).
Alfaro C; Teijeira A; Oñate C; Pérez G; Sanmamed MF; Andueza MP; Alignani D; Labiano S; Azpilikueta A; Rodriguez-Paulete A; Garasa S; Fusco JP; Aznar A; Inogés S; De Pizzol M; Allegretti M; Medina-Echeverz J; Berraondo P; Perez-Gracia JL; Melero I
Clin Cancer Res; 2016 Aug; 22(15):3924-36. PubMed ID: 26957562
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic Characterization and Isolation of Myeloid-Derived Suppressor Cells.
Reuven O; Mikula I; Ashkenazi-Preiser H; Twaik N; Ben-Meir K; Meirow Y; Daniel L; Kariv G; Kurd M; Baniyash M
Curr Protoc; 2022 Oct; 2(10):e561. PubMed ID: 36214619
[TBL] [Abstract][Full Text] [Related]
15. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer.
Tavukcuoglu E; Horzum U; Yanik H; Uner A; Yoyen-Ermis D; Nural SK; Aydin B; Sokmensuer C; Karakoc D; Yilmaz KB; Hamaloglu E; Esendagli G
Eur J Immunol; 2020 Dec; 50(12):2067-2074. PubMed ID: 32691408
[TBL] [Abstract][Full Text] [Related]
16. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
Ma P; Beatty PL; McKolanis J; Brand R; Schoen RE; Finn OJ
Front Immunol; 2019; 10():1401. PubMed ID: 31275327
[TBL] [Abstract][Full Text] [Related]
17. Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer.
Barrera L; Montes-Servín E; Hernandez-Martinez JM; Orozco-Morales M; Montes-Servín E; Michel-Tello D; Morales-Flores RA; Flores-Estrada D; Arrieta O
Cancer Immunol Immunother; 2018 Sep; 67(9):1393-1406. PubMed ID: 29974189
[TBL] [Abstract][Full Text] [Related]
18. High-Dimensional Analysis of Circulating and Tissue-Derived Myeloid-Derived Suppressor Cells from Patients with Glioblastoma.
Alban TJ; Bayik D; Alvarado AG; Kornblum HI; Lathia JD
Methods Mol Biol; 2021; 2236():157-175. PubMed ID: 33237547
[TBL] [Abstract][Full Text] [Related]
19. A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry.
Sacchi A; Tumino N; Grassi G; Casetti R; Cimini E; Bordoni V; Ammassari A; Antinori A; Agrati C
PLoS One; 2018; 13(8):e0202920. PubMed ID: 30161175
[TBL] [Abstract][Full Text] [Related]
20. Detection of Circulating and Tissue Myeloid-Derived Suppressor Cells (MDSC) by Flow Cytometry.
Sanchez-Pino MD
Methods Mol Biol; 2022; 2422():247-261. PubMed ID: 34859411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]